drugset / Trial / NCT01143129

Postoperative New-onset Atrial Fibrillation in Cardiac Surgery: DECS-PNAF Project

NCT01143129 ↗

Phase 4 Completed 80 enrolled UMC Utrecht
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The DExamethasone for Cardiac Surgery - Postoperative New-onset Atrial Fibrillation (DECS-PNAF) project described in this protocol aims to elucidate how corticosteroids protect cardiac surgical patients from Postoperative New-onset Atrial Fibrillation (PNAF). Patients will be randomized to receive either a single high dose of dexamethasone or a placebo. Continuous ECG-monitoring, echocardiography and biochemical and genomic analyses will be used to investigate the mechanisms responsible for the known protective effect of corticosteroids in the development of PNAF.

Timeline

Start
2011-01
Primary completion
2011-11
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1 mg/kg —

Indications